United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded May 18, 2026 · Filed May 19, 2026

On May 18, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$567.31 for US$5.67M under a trading plan, leaving 18,876 shares. Filed May 19, 2026 (Form 4).

Sold
10,000 shares
Price
US$567.31 average (US$562.91 to US$570.18)
Value
US$5.67M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockOption exercise2,500US$135.4221,376Direct
May 18, 2026Common StockOption exercise7,500US$117.7628,876Direct
May 18, 2026Common StockSale200US$562.9128,676Direct
May 18, 2026Common StockSale422US$564.3028,254Direct
May 18, 2026Common StockSale2,131US$565.4426,123Direct
May 18, 2026Common StockSale1,796US$566.3924,327Direct
May 18, 2026Common StockSale2,785US$568.4821,542Direct
May 18, 2026Common StockSale1,304US$568.4320,238Direct
May 18, 2026Common StockSale1,322US$569.5618,916Direct
May 18, 2026Common StockSale40US$570.1818,876Direct

Source

View original at SEC

Related